Search research articles
Contact Us
Filters
Showing results (251-260 of 268) with videos related to
Page
of 27
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in mice
Emma L Davies, James D Ramsden, Helen Cocks, et al.
Lancet (London, England)
|
May 7, 1983
Liposomally entrapped second antibody
R H Begent, A J Green, P A Keep, et al.
Cancer Immunology Research
|
February 26, 2015
Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
Yong Zheng, Greg Parsonage, Xiaodong Zhuang, et al.
British Journal of Cancer
|
September 1, 1989
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer
R H Begent, J A Ledermann, A J Green, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
C J Springer, K D Bagshawe, S K Sharma, et al.
Clinical and Experimental Immunology
|
November 1, 1989
Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies
H J Begent, K A Chester, K D Bagshawe, et al.
The British Journal of Surgery
|
January 1, 1986
Radioimmunolocalization and selection for surgery in recurrent colorectal cancer
R H Begent, P A Keep, F Searle, et al.
International Journal of Cancer
|
June 8, 2000
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase
S J Weedon, N K Green, I A McNeish, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs
Longqin Hu, Xinghua Wu, Jiye Han, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Use of second antibody in radioimmunotherapy
R H Begent, K D Bagshawe, R B Pedley, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 268) with videos related to
Sort By:
Page
of 27
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in mice
Emma L Davies, James D Ramsden, Helen Cocks, et al.
Lancet (London, England)
|
May 7, 1983
Liposomally entrapped second antibody
R H Begent, A J Green, P A Keep, et al.
Cancer Immunology Research
|
February 26, 2015
Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
Yong Zheng, Greg Parsonage, Xiaodong Zhuang, et al.
British Journal of Cancer
|
September 1, 1989
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer
R H Begent, J A Ledermann, A J Green, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
C J Springer, K D Bagshawe, S K Sharma, et al.
Clinical and Experimental Immunology
|
November 1, 1989
Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies
H J Begent, K A Chester, K D Bagshawe, et al.
The British Journal of Surgery
|
January 1, 1986
Radioimmunolocalization and selection for surgery in recurrent colorectal cancer
R H Begent, P A Keep, F Searle, et al.
International Journal of Cancer
|
June 8, 2000
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase
S J Weedon, N K Green, I A McNeish, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs
Longqin Hu, Xinghua Wu, Jiye Han, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Use of second antibody in radioimmunotherapy
R H Begent, K D Bagshawe, R B Pedley, et al.
Page
of 27